MET expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.291450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.319840E-01
Normal-vs-Stage2
1.078160E-01
Normal-vs-Stage3
2.504200E-01
Normal-vs-Stage4
1.399030E-01
Stage1-vs-Stage2
2.850600E-01
Stage1-vs-Stage3
4.973000E-01
Stage1-vs-Stage4
2.671000E-01
Stage2-vs-Stage3
2.049600E-01
Stage2-vs-Stage4
8.274200E-01
Stage3-vs-Stage4
2.067400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.354410E-01
Normal-vs-AfricanAmerican
1.256980E-01
Normal-vs-Asian
8.855600E-02
Caucasian-vs-AfricanAmerican
5.434400E-01
Caucasian-vs-Asian
6.136000E-01
AfricanAmerican-vs-Asian
4.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.390230E-01
Normal-vs-Female
1.210620E-01
Male-vs-Female
4.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.443000E-01
Normal-vs-Age(41-60Yrs)
7.544000E-02
Normal-vs-Age(61-80Yrs)
1.472410E-01
Normal-vs-Age(81-100Yrs)
2.190800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.340400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.507800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.975400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.043000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.001600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.328300E-02
Normal-vs-Daily Drinker
1.345800E-01
Normal-vs-Weekly Drinker
1.649760E-01
Normal-vs-Occasional Drinker
9.585400E-04
Normal-vs-Social Drinker
6.441700E-02
Non Drinker-vs-Daily Drinker
4.078200E-01
Non Drinker-vs-Weekly Drinker
4.930000E-01
Non Drinker-vs-Occasional Drinker
6.282300E-02
Non Drinker-vs-Social Drinker
1.301230E-01
Daily Drinker-vs-Weekly Drinker
2.450400E-01
Daily Drinker-vs-Occasional Drinker
2.012600E-01
Daily Drinker-vs-Social Drinker
6.092800E-01
Weekly Drinker-vs-Occasional Drinker
3.311600E-02
Weekly Drinker-vs-Social Drinker
8.822100E-02
Occasional Drinker-vs-Social Drinker
4.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.642000E-01
Normal-vs-Grade 2
1.016380E-01
Normal-vs-Grade 3
6.308000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.484200E-02
Grade 1-vs-Grade 3
6.844100E-04
Grade 1-vs-Grade 4
3.642000E-01
Grade 2-vs-Grade 3
1.684100E-02
Grade 2-vs-Grade 4
1.016380E-01
Grade 3-vs-Grade 4
6.308000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.533640E-01
Normal-vs-NonDiabetic
1.206420E-01
Diabetic-vs-NonDiabetic
6.726000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.641800E-02
Normal-vs-NoPancreatitis
1.285780E-01
Pancreatitis-vs-NoPancreatitis
1.106180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.106390E-01
Normal-vs-N1
1.257210E-01
N0-vs-N1
1.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.81200000000304E-05
Normal-vs-TP53-NonMutant
1.980760E-01
TP53-Mutant-vs-TP53-NonMutant
3.23769999699408E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
